Eurofins has announced the completion of the acquisition of Alba Science as part of its long-term strategy to develop and strengthen its capabilities in cosmetics and personal care testing.
"We are responding to growing demand for clinical studies by adapting our approach to expansion through acquisitions, strategic partnerships and investments," says the company.
The acquisition of Eurofins fits in with its 2021 strategy in a number of ways: by expanding existing capabilities, enabling the company to offer more clinical studies, sensory analysis and evaluation, gaining access to a large UK panelist database and customized imaging system, and getting closer to local and regional customers. The Scottish company is headquartered in Edinburgh and employs 23 people.
This acquisition will enable Eurofins to further consolidate its position in the global cosmetics testing market.
Judith Russell, Managing Director of Eurofins Consumer Product Testing Limited, said: "We are delighted to welcome Alba Science to the Eurofins team. This acquisition will enable us to expand our capabilities in the UK and is an excellent complement to the existing clinical network."
Marie Reynolds, Managing Director of Alba Science, commented, "Alba Science Ltd is delighted to become part of the Eurofins family, which will facilitate our ability to grow, providing high-level analytical services to our valued customer base with increased capacity and geographic expansion."
The company will henceforth be known as "Eurofins Alba".
